Morgan Stanley Gyrodyne, LLC Transaction History

Morgan Stanley

$1.39 Trillion
Q4 2024

A detailed history of Morgan Stanley transactions in Gyrodyne, LLC stock. As of the latest transaction made, Morgan Stanley holds 426 shares of GYRO stock, worth $3,557. This represents 0.0% of its overall portfolio holdings.

Number of Shares

426

Previous 425 0.24%

Holding current value

$3,557

Previous $3,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$7.68 - $11.1 $7 - $11	1 Added 0.24%	426 $3,000
Q3 2024 Nov 14, 2024	SELL	$7.67 - $8.14 $7,562 - $8,026	-986 Reduced 69.88%	425 $3,000
Q2 2024 Oct 17, 2024	BUY	$0.0 - $8.13 $0 - $4,878	600 Added 73.98%	1,411 $11,000
Q2 2024 Aug 14, 2024	BUY	$0.0 - $8.13 $0 - $4,878	600 Added 73.98%	1,411 $11,000
Q1 2024 Oct 17, 2024	SELL	$7.93 - $10.0 $4,758 - $6,000	-600 Reduced 42.52%	811 $6,000
Q1 2024 Aug 16, 2024	SELL	$7.93 - $10.0 $290,499 - $366,330	-36,633 Reduced 97.83%	811 $6,000
Q1 2024 May 15, 2024	SELL	$7.93 - $10.0 $290,499 - $366,330	-36,633 Reduced 97.83%	811 $6,000
Q4 2023 Aug 16, 2024	BUY	$8.95 - $10.58 $322,495 - $381,229	36,033 Added 2553.72%	37,444 $374,000
Q4 2023 Feb 13, 2024	BUY	$8.95 - $10.58 $333,172 - $393,851	37,226 Added 17076.15%	37,444 $374,000
Q4 2022 Feb 14, 2023	SELL	$8.1 - $11.04 $4,860 - $6,623	-600 Reduced 73.35%	218 $1,000
Q2 2022 Oct 27, 2022	BUY	$12.01 - $13.18 $456 - $500	38 Added 4.87%	818 $9,000
Q2 2022 Aug 15, 2022	BUY	$12.01 - $13.18 $456 - $500	38 Added 4.87%	818 $9,000
Q1 2022 Oct 27, 2022	SELL	$11.5 - $14.01 $437 - $532	-38 Reduced 4.65%	780 $11,000
Q3 2021 Nov 15, 2021	BUY	$12.0 - $13.54 $9,360 - $10,561	780 New	780 $10,000

Others Institutions Holding GYRO

# of Institutions

Shares Held

813K

Call Options Held

Put Options Held

View Full List

About Gyrodyne, LLC

Ticker GYRO
Exchange NASDAQ
Sector Real Estate
Industry Real Estate Services
Shares Outstandng 1,482,680
Market Cap $12.4M
Description
Gyrodyne, LLC. owns, leases and manages diverse commercial properties. The firm is distinguished by its service-oriented philosophy toward property ownership and management. Gyrodyne has grown from a largely Long Island player during the past into a diversified East Coast presence with an emphasis on medical office product.

More about GYRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account